Pacific Biosciences Reports Q4 Loss

Genomics company posts $40.4 million deficit in latest quarter

Published on Feb. 12, 2026

Got story updates? Submit your updates here. ›

Pacific Biosciences of California Inc. reported a loss of $40.4 million in its fourth quarter, according to an earnings report released on Thursday.

Why it matters

As a leading genomics technology company, Pacific Biosciences' quarterly financial performance is closely watched by investors and industry analysts to gauge the overall health and direction of the business.

The details

The company, based in Menlo Park, California, did not provide additional details about the factors contributing to the Q4 loss in its brief earnings snapshot.

  • Pacific Biosciences reported its Q4 2026 earnings on February 12, 2026.

The players

Pacific Biosciences of California Inc.

A genomics technology company that develops sequencing systems used in scientific research and clinical applications.

Got photos? Submit your photos here. ›

The takeaway

While the Q4 loss raises some concerns, Pacific Biosciences remains a major player in the genomics industry. Investors will be closely monitoring the company's performance in the coming quarters to assess its long-term growth trajectory.